2012
DOI: 10.1089/jop.2011.0082
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Epidemic Keratoconjunctivitis with 2% Povidone–Iodine: A Pilot Study

Abstract: Ocular application of 2% PVP-I was tolerable. This measure successfully relieved ocular discomfort from EKC in 3 quarters of the study group within a week. A randomized, controlled trial is required to verify the benefit of this measure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
15
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(16 citation statements)
references
References 14 publications
0
15
0
1
Order By: Relevance
“…Several adenoviruses including HAdV-8, HAdV-19 and HADV-37 (in HAdV-D) are responsible from severe and contagious EKC which can be related to a nosocomial infection or community acquired (4, 1012).…”
Section: Introductionmentioning
confidence: 99%
“…Several adenoviruses including HAdV-8, HAdV-19 and HADV-37 (in HAdV-D) are responsible from severe and contagious EKC which can be related to a nosocomial infection or community acquired (4, 1012).…”
Section: Introductionmentioning
confidence: 99%
“…The clinical presentation of the presumed viral conjunctivitis is characterized by acute symptoms, such as eye irritation, excessive tearing, soreness, foreign body sensations, light sensitivity and even blurred vision in advanced cases. Ocular findings include blepharedema, epiphora, conjunctival hyperemia, chemosis, follicular reaction, subconjunctival hemorrhage and membrane or pseudomembrane formation 6 . Laboratory confirmation of the diagnosis can aid physicians in rapidly initiating suitable hygienic measures and determining the epidemiological significance of the infection.…”
Section: Introductionmentioning
confidence: 99%
“…Povidone-iodine 2% was used in a pilot study four times a day for a week and led to recovery in three quarters of eyes [72]. A fixed combination of povidone-iodine and dexamethasone for EKC is in clinical trials.…”
Section: Treatmentsmentioning
confidence: 99%